Laparoscopic Fertility-Sparing Management of Borderline Ovarian Tumors: Surgical and Long-Term Oncological Outcomes
Journal of Clinical Medicine · 14.09.2024 · 13 (18) · 5458
DOI: 10.3390/jcm13185458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.09.2024. Verfasst von Marta Tortajada Valle und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology Oncology Unit, Institute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To assess the long-term oncological safety of laparoscopic fertility-sparing surgery (FSS) in borderline ovarian tumors and the impact of laparoscopic surgical factors on recurrences. Primary outcomes were the recurrence rate and time to recurrence after laparoscopic FSS. Secondary outcomes were to evaluate the recurrence rate after a second laparoscopic surgery and to assess factors associated with the risk of relapse.
Methods
This is a retrospective single-center observational study in a tertiary university-affiliated hospital. Thirty-four patients diagnosed with borderline ovarian tumors who underwent laparoscopic FSS were recruited. Patients were categorized into two groups: the adnexectomy group, including patients who underwent unilateral adnexectomy, and the cystectomy group, which included patients who underwent unilateral cystectomy, bilateral cystectomy, and unilateral adnexectomy with contralateral cystectomy.
Results
Eleven relapses (32.3%) were observed during a median follow-up period of 116.1 [62.5–185.4] months. The recurrence rate was similar for patients who underwent cystectomy (6/19, 31.6%) and adnexectomy (5/15, 33.3%). Cystectomy led to a shorter time to first recurrence (36-month progression-free survival rates of 66% vs. 85%) and higher rates of capsular rupture (71.4% vs. 20%, p = 0.04) compared to adnexectomy. No deaths due to progression of disease were reported.
Conclusions
Laparoscopic FSS for borderline ovarian tumors is a safe, long-term oncological option. Although the recurrence rate was similar in patients undergoing adnexectomy or cystectomy, the time to recurrence was shorter in cases treated with cystectomy. Further research is needed to identify eventual laparoscopic risk factors more strongly correlated with recurrence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecology Oncology Unit, Institute Clinic of Gynecology, Obstetrics, and Neonatology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.
- Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
- Faculty of Medicine, University of Barcelona, 08036 Barcelona, Spain.
ORCID-Profile: Marta Tortajada Valle, Núria Agustí, Pere Fusté, Eduard Mensión, Berta Díaz-Feijóo, Aureli Torné
Zitieren
APA
Tortajada Valle, M., Agustí, N., Fusté, P., Mensión, E., Díaz-Feijóo, B., Glickman, A., Marina, T., & Torné, A. (2024). Laparoscopic Fertility-Sparing Management of Borderline Ovarian Tumors: Surgical and Long-Term Oncological Outcomes. Journal of Clinical Medicine, 13(18), 5458. https://doi.org/10.3390/jcm13185458
Vancouver
Tortajada Valle M, Agustí N, Fusté P, Mensión E, Díaz-Feijóo B, Glickman A, et al. Laparoscopic Fertility-Sparing Management of Borderline Ovarian Tumors: Surgical and Long-Term Oncological Outcomes. Journal of Clinical Medicine. 2024;13(18):5458. doi:10.3390/jcm13185458
BibTeX
@article{TortajadaValle2024,
author = {Tortajada Valle, Marta and Agustí, Núria and Fusté, Pere and Mensión, Eduard and Díaz-Feijóo, Berta and Glickman, Ariel and Marina, Tiermes and Torné, Aureli},
title = {Laparoscopic Fertility-Sparing Management of Borderline Ovarian Tumors: Surgical and Long-Term Oncological Outcomes},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {18},
pages = {5458},
doi = {10.3390/jcm13185458}
}
EUVIMED